The relationship of essential tremor to other movement disorders: Report on 678 patients

Annals of Neurology

Volumn 35, Issue 6, 1994, Pages 717-723

  Koller, William C ^a   Busenbark, Karen ^a   Miner, Kevin ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTICONVULSIVE AGENT; CLONAZEPAM; DIAZEPAM; METHAZOLAMIDE; NADOLOL; PRIMIDONE; PROPRANOLOL;

AGED; ALCOHOL CONSUMPTION; ARTICLE; DYSTONIA; ESSENTIAL TREMOR; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MYOCLONUS; ONSET AGE; PARKINSON DISEASE; PHYSICAL DISABILITY; PRIORITY JOURNAL; WORK DISABILITY;

AGED; ALCOHOL DRINKING; DATABASES, FACTUAL; FEMALE; HUMAN; LATERALITY; MALE; MIDDLE AGE; MOVEMENT DISORDERS; SMOKING; SUPPORT, NON-U.S. GOV'T; TREMOR;

EID: 0028298499     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410350613     Document Type: Article

References (53)

1. Essential tremor
2. Association between essential tremor and Parkinson's disease
3. Lack of association between essential tremor and Parkinson's disease
4. Essential tremor: clinical correlates in 350 patients
5. Is there a relationship between Parkinson's disease and essential tremor
6. Paralysis agitans
7. Essential tremor
8. Tremors in early Parkinson's disease
9. Essential tremor: a clinical and genetic population study
10. Essential tremor in Rochester, Minnesota: a 45‐year study
11. New data on the genetics of Parkinson's disease
12. Family history of tremor in Parkinson's disease compared with those of controls and patients with idiopathic dystonia
13. A family study of parkinsonism
14. The relation of essential tremor to Parkinson's disease
15. Epidemiology of Parkinson's disease
16. Does a long preclinical period occur in PD?
17. Aging and Parkinson's disease: substantia nigra regional selectivity
18. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration
19. Olfactory function in essential tremor
20. Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease
21. Detection of preclinical Parkinson's disease with PET
22. Isolated tremor and disruption of the nigrostriatal dopaminergic system
23. The relevance of the lewy body to the pathogenesis of idiopathic Parkinson's disease
24. Clinicopathologic observations in essential tremor: report of six cases
25. Dystonia and tremor in spasmodic torticollis
26. Idiopathic cervical dystonia: clinical characteristics
27. Cervical dystonia: clinical findings and associated movement disorders
28. Spasmodic torticollis
29. Essential tremor and dystonia
30. Dystonia musculoram deformans: analysis with electromyograph
31. Tremor and idiopathic dystonia
32. Dystonia gene in Ashkerazi Jewish population located on chromosome 9q32–34
33. Linkage analysis with chromosome 9 markers in hereditary essential tremor
34. Essential tremor and dystonic syndrome
35. Different clinical features of essential tremor: a 200 patient study
36. Essential tremor in a Finnish population
37. Handedness and essential tremor
38. The inheritance of left‐handedness
39. Effect of alcohol on tremor: comparison to propranolol
40. Der essentielle tremor, Phänomenologie und Epidemiologie
41. Clinical manifestation of essential tremor
42. Essential tremor in Nigerians: a prospective study of 35 cases
43. Epidemiology of essential tremor
44. Combined resting‐postural tremor
45. Diagnosis and treatment of tremor
46. Is essential tremor benign?
47. Acute and chronic effects of propranolol and primidone in essential tremor
48. A double‐blind trial of clonazepam in benign essential tremor
49. Efficacy of alprazolam for essential tremor
50. Treatment of essential tremor with methazolamide
51. Double‐blind controlled study of methazolamide in the treatment of essential tremor